Tag: SARSCoV2
Published Research Shows Initial Results from SARS-CoV-2 Surveillance Studies Su… –...
INNOVATIVE RESPONSE SUPPORTS FUTURE RESPONSES AGAINST SIMILAR PANDEMIC THREATS
First results from the CDC SARS-CoV-2 U.S. variant surveillance program to be published
Positive COVID samples...
Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in Clinical Trials, Mar… –...
NANJING, China, April 18, 2022 /PRNewswire/ -- On April 15, 2022, Simcere Pharmaceutical (2096.HK), an innovation and R&D driven pharmaceutical company in China held...
Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody...
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for...
Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- Diazyme announces that it has received a reissued Emergency Use Authorization (EUA) for...